MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $20.8 million in its fourth quarter.
The Menlo Park, California-based company said it had a loss of 18 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The maker of genetic analysis technology posted revenue of $24.9 million in the period.
For the year, the company reported that its loss widened to $92.2 million, or 87 cents per share. Revenue was reported as $93.5 million.
In the final minutes of trading on Thursday, the company's shares hit $2.82. A year ago, they were trading at $4.84.
—————
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PACB at https://www.zacks.com/ap/PACB